Search Page

1

Cite

Share

COVID-19 vaccine-associated subacute thyroiditis: an unusual suspect for de Quervain's thyroiditis.

Jeeyavudeen MS, Patrick AW, Gibb FW, Dover AR. Jeeyavudeen MS, et al. Among authors: dover ar. BMJ Case Rep. 2021 Nov 9;14(11):e246425. doi: 10.1136/bcr-2021-246425. BMJ Case Rep. 2021. PMID: 34753732 Free PMC article.

Cite

Share

2

Cite

Share

Intra-vascular glucocorticoid metabolism as a modulator of vascular structure and function.

Hadoke PW, Macdonald L, Logie JJ, Small GR, Dover AR, Walker BR. Hadoke PW, et al. Among authors: dover ar. Cell Mol Life Sci. 2006 Mar;63(5):565-78. doi: 10.1007/s00018-005-5427-2. Cell Mol Life Sci. 2006. PMID: 16416027 Review.

Cite

Share

3

Cite

Share

Socioeconomic deprivation, technology use, C-peptide, smoking and other predictors of glycaemic control in adults with type 1 diabetes.

Dover AR, Strachan MWJ, McKnight JA, Stimson RH, Mackenzie SD, Lyall MJ, Wright RJ, Forbes S, Gibb FW. Dover AR, et al. Diabet Med. 2021 Mar;38(3):e14445. doi: 10.1111/dme.14445. Epub 2020 Nov 17. Diabet Med. 2021. PMID: 33128811

Cite

Share

4

Cite

Share

Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring.

Dover AR, Ritchie SA, McKnight JA, Strachan MWJ, Zammitt NN, Wake DJ, Forbes S, Stimson RH, Gibb FW. Dover AR, et al. Diabet Med. 2021 Jan;38(1):e14374. doi: 10.1111/dme.14374. Epub 2020 Sep 28. Diabet Med. 2021. PMID: 32740984 Free PMC article.

Cite

Share

5

Cite

Share

Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosis.

Aung ET, Zammitt NN, Dover AR, Strachan MWJ, Seckl JR, Gibb FW. Aung ET, et al. Among authors: dover ar. Clin Endocrinol (Oxf). 2019 Jan;90(1):192-199. doi: 10.1111/cen.13873. Epub 2018 Oct 25. Clin Endocrinol (Oxf). 2019. PMID: 30291728

Cite

Share

6

Cite

Share

Substantial HbA1c Reduction Following Intermittent-Scanning Continuous Glucose Monitoring Was Not Associated With Early Worsening of Retinopathy in Type 1 Diabetes.

Linton K, Stimson RH, Dover AR, Forbes S, Madill K, Annoh R, Strachan MWJ, McKnight JA, Wright RJ, Gibb FW. Linton K, et al. Among authors: dover ar. J Diabetes Sci Technol. 2021 Feb 19:1932296821994091. doi: 10.1177/1932296821994091. Online ahead of print. J Diabetes Sci Technol. 2021. PMID: 33605149

Cite

Share

7

Cite

Share

HbA1c response and hospital admissions following commencement of flash glucose monitoring in adults with type 1 diabetes.

Stimson RH, Dover AR, Ritchie SA, Wright RJ, McKnight JA, Zammitt NN, Gibb FW. Stimson RH, et al. Among authors: dover ar. BMJ Open Diabetes Res Care. 2020 Jul;8(1):e001292. doi: 10.1136/bmjdrc-2020-001292. BMJ Open Diabetes Res Care. 2020. PMID: 32719078 Free PMC article.

Cite

Share

8

Cite

Share

Inhibition or deletion of 11β-HSD1 does not increase angiogenesis in ischemic retinopathy.

Davidson CT, Dover AR, McVicar CM, Megaw R, Glenn JV, Hadoke PWF, Stitt AW, Walker BR. Davidson CT, et al. Among authors: dover ar. Diabetes Metab. 2017 Oct;43(5):480-483. doi: 10.1016/j.diabet.2016.12.001. Epub 2017 Jan 11. Diabetes Metab. 2017. PMID: 28089372 Free article. No abstract available.

Cite

Share

9

Cite

Share

Flash Glucose Monitoring Improves Outcomes in a Type 1 Diabetes Clinic.

Dover AR, Stimson RH, Zammitt NN, Gibb FW. Dover AR, et al. J Diabetes Sci Technol. 2017 Mar;11(2):442-443. doi: 10.1177/1932296816661560. Epub 2016 Jul 28. J Diabetes Sci Technol. 2017. PMID: 27464754 Free PMC article. No abstract available.

Cite

Share

10

Cite

Share

HbA1c reduction following flash monitoring commencement is not independently associated with adverse diabetic eye disease outcomes in type 1 diabetes.

Al-Dalla Ali M, Stimson RH, Dover AR, Forbes S, Annoh R, Madill K, Gibb FW. Al-Dalla Ali M, et al. Among authors: dover ar. BMJ Open Diabetes Res Care. 2020 Nov;8(2):e001668. doi: 10.1136/bmjdrc-2020-001668. BMJ Open Diabetes Res Care. 2020. PMID: 33132212 Free PMC article.

Cite

Share